February 26, 2022 Comments Off on New patent for Rigel Pharms drug TAVALISSE Posted in: Patent Added Annual Drug Patent Expirations for TAVALISSE Tavalisse is a drug marketed by Rigel Pharms Inc and is included in one NDA. There are fourteen patents protecting this drug. This drug…
The post New patent for Rigel Pharms drug TAVALISSE appeared first on …
February 26, 2022 Comments Off on New patent for Msd Merck drug PIFELTRO Posted in: Patent Added Annual Drug Patent Expirations for PIFELTRO Pifeltro is a drug marketed by Msd Merck Co and is included in one NDA. It is available from one supplier. There is one…
The post New patent for Msd Merck drug PIFELTRO appeared first on DrugPatentWatch – Mak…